Hyman Steven 4
4 · Cyclerion Therapeutics, Inc. · Filed Jul 26, 2022
Insider Transaction Report
Form 4
Hyman Steven
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-25+57,753→ 57,753 totalExercise: $0.78Exp: 2032-07-25→ Common Stock (57,753 underlying)
Footnotes (1)
- [F1]The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.